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A clone expressing an immunoreactive protein with an apparent molecular mass of 44 kDa was selected from
an Ehrlichia chaffeensis Arkansas genomic library by probing with anti-E. chaffeensis hyperimmune mouse
ascitic fluid. Nucleotide sequencing revealed an open reading frame (ORF) capable of encoding a 198-amino-
acid polypeptide. The ORF contained four imperfect, direct, tandem 90-bp repeats. The nucleotide and deduced
amino acid sequences did not show close homologies to entries in the molecular databases. PCR with primers
whose sequences matched the sequences flanking the ORF was performed with DNA samples extracted from
cell cultures infected with nine different isolates of E. chaffeensis, blood samples from seven patients with
monocytic ehrlichiosis, and Amblyomma americanum ticks collected in four different states. The resulting amplicons
varied in length, containing three to six repeat units. This gene, designated the variable-length PCR target, is
useful for PCR detection of E. chaffeensis and differentiation of isolates.
Human ehrlichiosis was first described in the United States
in 1987 (17), and the first isolation of an Ehrlichia species from
a North American patient was reported in 1991 (8). The or-
ganism was designated a new species, Ehrlichia chaffeensis,
because the 16S rRNA gene sequence of the isolate was sig-
nificantly different from that of previously described Ehrlichia
species (2). Infection with E. chaffeensis results in a moderate
to severe febrile illness observed most frequently in the south-
eastern and south-central regions of the United States (11, 13,
28). Over 70% of patients describe a history of tick bite or
exposure 1 to 2 weeks preceding the illness. Several studies
have implicated the lone star tick, Amblyomma americanum, as
the primary vector of E. chaffeensis (4, 12, 16). Approximately
750 cases of E. chaffeensis infection have been confirmed se-
rologically by the Centers for Disease Control and Prevention
(CDC) to date (5).
The emergence or recognition of human diseases caused by
tick-transmitted ehrlichiae has stimulated interest in the mo-
lecular biology of these obligate intracellular bacteria. The
cloning and characterization of several antigen-expressing
genes belonging to E. chaffeensis have recently been described,
including the groESL heat shock operon (24, 25) and the 120-
kDa immunodominant surface protein gene (29, 30). Ohashi et
al. (18) and Reddy et al. (22) have described a multigene family
of E. chaffeensis that demonstrates homology to major surface
antigen genes (MAP 1) of a closely related bacterium, Cowdria
ruminantium (21, 27).
Initially, E. chaffeensis was isolated and propagated in cell
culture with difficulty, but more recently, multiple isolations of
this pathogen from human patients from several geographic
areas have been described. The original isolate was designated
the Arkansas strain (2, 8). The 91HE17 and Sapulpa isolates
were described in 1995 (10) and 1997 (6), respectively. Since
1996, six additional isolates of E. chaffeensis have been ob-
tained at CDC from blood samples from patients with ehrli-
chiosis (reference 19 and data herein). The availability of mul-
tiple isolates now provides ample material for the study of the
molecular and immunologic diversity among different strains
of E. chaffeensis. In this report, we describe the cloning and
sequencing of an E. chaffeensis gene containing repetitive
sequence motifs. We have referred to this gene as the variable-
length PCR target (VLPT) and have described sequence dif-
ferences among PCR products amplified from the Arkansas,
Jax, and St. Vincent isolates of E. chaffeensis (19). In this
report, we describe the detection of VLPT by PCR in a variety
of samples from different sources, sequence variation among
the amplicons, and recombinant expression of the VLPT pro-
tein in Escherichia coli.
MATERIALS AND METHODS
Isolation and cultivation of E. chaffeensis. The Arkansas, 91HE17, Sapulpa,
Jax, and St. Vincent isolates of E. chaffeensis were obtained from clinical samples
as described previously (6, 8, 10, 19). The Liberty, Osceola, Wakulla, and West
Paces isolates were recovered from EDTA-anticoagulated whole blood collected
from patients with clinical disease by a previously described method (19). Briefly,
patient blood samples (1 to 5 ml) were diluted with 2 volumes of sterile Hanks’
balanced salt solution and layered onto Histopaque 1083 (Sigma Diagnostics, St.
Louis, Mo.). The prepared samples were centrifuged at 400 3 g for 10 min. The
leukocyte pellets were resuspended in culture medium (minimal essential me-
dium containing Earle’s salts and 16 mM sodium bicarbonate [GIBCO BRL,
Grand Island, N.Y.], 8.8% heat-inactivated fetal bovine serum [Hyclone Labo-
ratories, Logan, Utah], 1.8 mM L-glutamine [GIBCO BRL], 0.1 mM minimal
essential medium with nonessential amino acids [GIBCO BRL], and 8.8 mM
HEPES buffer [GIBCO BRL]). Semiconfluent monolayers of DH82 cells in a
25-cm2 polystyrene cell culture flask were inoculated with the cell suspensions.
Cultures were incubated at 37°C in a 5.0% CO2 atmosphere. Isolates of E.
chaffeensis were maintained in continuous culture in DH82 cells as described
previously (8, 19).
Construction of genomic expression library. Cell-free preparations of E.
chaffeensis Arkansas were obtained from infected DH82 cell cultures as de-
scribed previously (24). DNA was extracted by proteinase K digestion and phe-
nol-chloroform extraction and was fragmented for library construction by using
EcoRI star activity (1). DNA fragments from 2 to 10 kb in size were isolated by
agarose gel electrophoresis and were cloned into Stratagene’s Lambda Zap II
vector by the procedures recommended by the manufacturer (Stratagene, La
Jolla, Calif.).
Immunoscreening of expression library. Clones were screened by using anti-
E. chaffeensis hyperimmune mouse ascitic fluid (HMAF; kindly provided by Tom
Ksiazek, Special Pathogens Branch, CDC). Preparation of HMAF has been
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described previously (14). Recombinant clones expressing reactive proteins were
selected by immunoscreening phage plaques on lawns of E. coli XL-1 Blue.
Nitrocellulose filters soaked in 10 mM isopropyl-b-D-thiogalactopyranoside and
placed over lawns during plaque formation were reacted with a 1:200 dilution of
HMAF for 1 h in Tris-buffered saline containing Tween 20 (TBST). The filters
were washed three times in TBST and reacted for 1 h with anti-mouse immu-
noglobulin G (heavy and light chains) peroxidase conjugate (Kirkegaard & Perry
Laboratories, Gaithersburg, Md.) diluted 1:5,000 in TBST. The filters were then
washed three times with TBST and reacted with tetramethylbenzidine membrane
substrate (Kirkegaard & Perry). Immunoreactive plaques were subjected to three
rounds of plaque purification. Phagemids from reactive plaques were rescued
and excised by the Stratagene protocol, producing pBluescript plasmids contain-
ing inserts.
Immunoblotting. E. coli containing excised recombinant phagemid or trans-
formed with plasmid subclones was grown overnight at 37°C in 5 ml of Luria
broth containing ampicillin (100 mg/ml). Fresh cultures containing 1 mM isopro-
pyl-b-D-thiogalactopyranoside were subsequently inoculated with 50 ml of the
overnight culture. Several 200-ml samples were removed when the optical density
of the culture reached 0.3 to 0.4 (600-nm wavelength), and the bacterial cells
were pelleted by centrifugation at 10,000 3 g for 3 min. The bacteria were
resuspended in sample buffer (Novex, San Diego, Calif.) containing 5% 2-mer-
captoethanol and 1% sodium dodecyl sulfate (SDS), heated at 100°C for 5 min,
and centrifuged at 10,000 3 g for 3 min. Ten-microliter samples of each super-
natant were loaded into individual wells of 4 to 20% gradient Tris-glycine-SDS
gels (Novex) for SDS-polyacrylamide gel electrophoresis at 100 V for 90 min.
The proteins were transferred to nitrocellulose membranes (Novex) for 2 h at 90
V with a Mini-Transblot Cell (Bio-Rad, Hercules, Calif.). The filters were re-
acted with the HMAF as described above for immunoscreening.
Subcloning. The restriction endonucleases, calf intestinal alkaline phospha-
tase, and T4 DNA ligase used for mapping and the construction of subclones
were obtained from Boehringer Mannheim, Indianapolis, Ind., or New England
Biolabs, Beverly, Mass. Some subclones were made by cloning PCR products
directly into the T/A cloning vector pGEM-T (Promega Corp., Madison, Wis.)
according to the manufacturer’s recommendations.
Nucleotide sequencing. Plasmids were purified with Wizard Minipreps (Pro-
mega Corp., Madison, Wis.), and Wizard PCR preps (Promega Corp.) were used
for purification of PCR products. PCR products were sequenced directly, with
the exception of one product obtained from an individual tick (tick 97-36; see
Table 1) that was cloned into plasmid pGEM-T prior to sequencing (Promega
Corp.). If gel purification was necessary prior to sequencing, 40 ml of the indi-
vidual PCR mixture was electrophoresed in gels containing 1.2% low-melting-
point agarose (Boehringer Mannheim) and the appropriate band was excised.
Purified preparations were sequenced with the Prism Ready Reaction DyeDeoxy
Cycle Sequencing kit (Applied Biosystems, Foster City, Calif.) and a Perkin-
Elmer 9600 thermocycler. Thermocycler parameters for sequencing were 96°C
for 1 min, 50°C for 15 s, and 60°C for 4 min for 25 cycles. Unincorporated
fluorescence-labeled deoxynucleoside triphosphates were removed with Centri-
Sep columns according to the manufacturer’s recommendations (Princeton Sep-
arations, Inc., Adelphia, N.J.). Samples were loaded onto 5% polyacrylamide
gels for electrophoresis and detection on Applied Biosystem model 370A or 377
automated sequencers. Both strands were sequenced, initially by primer walking
and later with established primer sets.
Samples selected for analysis of the VLPT gene. Three categories of specimens
were evaluated by PCR for detection of the VLPT gene (see Table 1): (i)
EDTA-anticoagulated whole-blood samples from patients with E. chaffeensis
infection confirmed by PCR with primers HE1 and HE3 (3) for detection of the
16S rRNA gene; (ii) nine isolates of E. chaffeensis, in DH82 cells, obtained from
human patients (Arkansas, 91HE17, and Sapulpa [kindly provided by D. H.
Walker], Jax, St. Vincent, Osceola, Wakulla, Liberty, and West Paces); and (iii)
individual and pooled A. americanum ticks collected from geographic regions
where E. chaffeensis is endemic.
Extraction of E. chaffeensis DNA from patient blood, isolates, and ticks. DNA
was extracted from 200 ml of patient whole blood by using the QIAmp Blood Kit
(Qiagen Inc., Santa Clarita, Calif.) according to the manufacturer’s recommen-
dations. Similarly, DNA was extracted from 20 ml of supernatant from E.
chaffeensis-infected DH82 cell cultures. Individual ticks were minced in a cryo-
tube with a sterile scalpel blade, and DNA was extracted with QIAmp tissue kits
(Qiagen, Inc.). Extraction of DNA from pooled A. americanum ticks (see Table
2) was conducted at CDC’s Ft. Collins facility as part of a previous study, and the
extraction procedure has been described previously (4, 15).
PCR amplification. PCRs were performed with GeneAmp kits (Roche Mo-
lecular Systems, Inc., Branchburg, N.J.) according to the manufacturer’s recom-
mendations and Perkin-Elmer thermal cyclers. Ten microliters from each DNA
extraction was added to 90 ml of the master mixture for each 100-ml PCR
mixture. The final reagent concentrations were 0.5 mM each primer, 2.5 U of
AmpliTaq DNA polymerase per reaction mixture, 10 mM Tris-HCl (pH 8.3), 50
mM KCl, 1.5 mM MgCl2, and each deoxynucleoside triphosphate at a concen-
tration of 200 mM. The following thermocycler parameters were used: 3 cycles of
94°C (1 min), 52°C (2 min), and 70°C (90 s), followed by 37 cycles of 88°C (1
min), 55°C (2 min), and 70°C (90 s), followed by an extension period (68°C, 5
min). VLPT primers FB5A (59-GTGACATCTTAGTTTAATAGAAC) and
FB3A (59-AAGACTGAAACGTTATAGAG) were used in primary PCRs.
Nested PCR with primers FB5 (59-AAATAGGGTATAAATATGTCAC) and
FB3 (59-GCCTAATTCAGATAAACTAAC) was performed with extracts from
individual ticks. One microliter of the primary PCR product was used as a
template in the nested reactions. The cycling parameters for the nested PCRs
were the same as those used for the primary reactions. Samples were also tested
by a PCR assay with primers HE1 and HE3 targeted to the 16S rRNA gene
(rDNA) of E. chaffeensis as described by Anderson et al. (3). In addition, extracts
from individual isolates in cell culture were tested by PCR with primers WF1 and
WR2 for amplification of the 120-kDa antigen gene as described by Yu et al.
(29). PCR products were detected by electrophoresis of 10-ml samples in 1.4%
Tris-acetate agarose gels containing ethidium bromide.
Computer analysis of sequence data. Nucleotide sequences were edited and
assembled with the TED and XBAP programs of the STADEN sequence anal-
ysis package (23). Nucleotide sequence homology searches were made through
the National Center for Biotechnology Information BLAST network service.
Sequence homology comparisons were made with the GAP program of the GCG
package (Genetics Computer Group, Madison, Wis.). Multiple-sequence align-
ments were made with the PILEUP and PRETTY programs of the GCG pack-
age.
Nucleotide sequence accession numbers. The nucleotide sequence accession
numbers for the complete VLPT sequences of the following E. chaffeensis iso-
lates are as indicated: 91HE17, AF121237; Arkansas, AF121232; Jax, AF121234;
Liberty, AF121236; Osceola, AF121233; Sapulpa, AF121230; St. Vincent,
AF121231; Wakulla, AF121238; and West Paces, AF121235.
RESULTS
Sequence analysis of E. chaffeensis Arkansas clone. pBluescript
clones derived from 10 immunoreactive plaques were analyzed
by SDS-polyacrylamide gel electrophoresis and immunoblot-
ting with HMAF. Three of 10 clones expressed an immunore-
active protein that comigrated with an E. chaffeensis Arkansas
protein with an apparent molecular mass of approximately 44
kDa. Restriction endonuclease digestion with EcoRI showed
that each of the three clones contained an insert of approxi-
mately 7 kb, and nucleotide sequencing with M13 universal and
reverse primers showed identical sequences for the inserts of
each clone near the plasmid junction. One clone was selected
for further analysis. After restriction mapping, subclones were
made and screened for protein expression. A subclone con-
taining a 2.6-kb fragment of the original insert expressed a
44-kDa protein. The complete insert was sequenced by primer
walking. The longest open reading frame (ORF) encoded a
198-amino-acid polypeptide, approximately one-half the size
predicted for a 44-kDa protein. A sequence compatible with a
ribosome-binding site was found 11 bp upstream of the putative
ATG start codon (Fig. 1). Multiple stop codons were found down-
stream of the first stop codon, and homologous sequences were
not found elsewhere in the insert. Sequence homology
searches with the nucleotide and deduced amino acid se-
quences did not show significant similarities to entries in the
genetic databases.
VLPT PCR. Multiple sample types were evaluated by using
the primers derived from the sequenced clone. Analysis of
sequences from nine isolates, seven clinical whole-blood spec-
imens, seven A. americanum tick pools, and one individual tick
are listed in Table 1. Amplicons of four different sizes were
produced, with each differing in apparent size by a factor of 90
bp (Fig. 2). Nucleotide sequencing revealed that the size dif-
ferences resulted from variations in the number of repeat
units. The corresponding patient blood samples from which six
of the isolates (Jax, Liberty, Osceola, St. Vincent, Wakulla, and
West Paces) were obtained were tested individually. For each
blood sample, the VLPT sequence was identical to the VLPT
sequence of the corresponding isolate (data not shown). The
seven blood samples listed in Table 1 were collected from
ehrlichiosis patients for whom isolates were not obtained.
In addition to demonstrating concordance between repeat
unit number for isolates and the corresponding whole blood
samples, we investigated whether the number of repeat units in
the VLPT remained stable with passage in cell culture. DNA
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samples were extracted from the St. Vincent, Jax, Osceola, and
Wakulla isolates after the eighth cell culture passage. The sizes
of the amplicons obtained from patient blood samples were
identical to those obtained from the corresponding isolate af-
ter the eighth cell culture passage, indicating that the number
of repeat units remained stable through multiple passages in
cell culture.
PCR specificity. DNA samples extracted from the blood of a
healthy patient and uninfected DH82 cells were included as
negative controls and did not produce amplicons. DNA sam-
ples extracted from related bacteria were tested in PCRs with
VLPT primers (FB5A-FB3A and FB5-FB3) to assess primer
specificity. Samples included DNA extracted from cultures in-
dividually infected with the human granulocytic ehrlichiosis
agent (strain USG3), Ehrlichia canis Florida, Ehrlichia muris
AS145, and Ehrlichia risticii HRC-IL and from purified
Anaplasma marginale Virginia, Bartonella henselae Houston 1,
and Rickettsia rickettsii R. DNA extracted from E. coli XL-1
Blue, which was used for construction of the genomic library,
was also tested. None of the DNA samples produced bands of
significant intensity and size compatible with those of the
VLPT amplicons obtained from E. chaffeensis. DNA extracted
from whole blood from a dog naturally infected with Ehrlichia
ewingii produced an amplicon of approximately 1,600 bp in a
primary PCR with primers FB5A and FB3A. This amplicon
was sequenced and did not contain an ORF with sequence
homology to VLPT. DNA samples extracted from several
strains of C. ruminantium were tested with VLPT primers FB5
and FB3, and amplicons of different sizes were obtained from
different strains; however, none of the products hybridized
with a labeled E. chaffeensis VLPT probe (20a).
Detection of E. chaffeensis in ticks. To determine whether
VLPT PCR would be useful for detection of E. chaffeensis in
ticks and to determine whether a variable number of repeat
units would also be present in samples of nonhuman origin, 10
pools of A. americanum ticks were tested with primers FB5A
and FB3A. Seven of the pools were selected on the basis of
previous positive results for the E. chaffeensis 16S rDNA (4)
and three pools that produced negative results were selected as
controls (Table 2). The VLPT PCR results (Table 2) showed
an exact correlation with the 16S rDNA PCR results. Three
VLPT amplicon sizes were obtained, and these corresponded
to three, four, or five repeat units (Table 1). Two bands were
visible in the PCR product from pool 95: a bright band comi-
grating with a three-repeat unit marker and a faint band comi-
grating with a four-repeat unit marker (data not shown). We
were not able to recover sufficient DNA from the faint band for
sequencing, but these results may indicate that more than one
variant was detected in the pool.
Nested VLPT PCR was performed with DNA extracted
from 42 individual adult A. americanum ticks collected in
Baker County, Fla. Negative controls, a water extraction blank,
and a colony-raised adult female A. americanum tick did not
produce products. As a positive control, an adult female A.
americanum tick infected with E. chaffeensis Arkansas by cap-
illary feeding (20) produced a four-repeat-unit amplicon, as
expected. Six of 42 tick extracts produced amplicons of the
VLPT four-repeat-unit size. One of the six amplicons was
sequenced and was confirmed to be VLPT (Table 1). Primary
PCR with VLPT primer pair FB5A-FB3A and 16S rDNA
primer pair HE1-HE3 did not produce visible products from
individual ticks.
Sequence variation among VLPT amplicons. The amplicons
were sequenced to confirm their identities and to characterize
the sequence variations. Variations occurred at several levels,
including the number and sequences of repeat units, the oc-
currence of a codon deletion (aspartic acid residue) immedi-
ately preceding the first repeat unit, the occurrence of a 9-bp
deletion in the region downstream of the coding sequence, and
single substitutions in certain nucleotide positions (Table 1 and
Fig. 1).
Amplicons from different samples contained three to six
repeat units, representing the four different sizes. To facilitate
characterization of sequence differences, the deduced amino
acid sequences of the repeat units from all amplicons were
aligned, and type numbers were assigned for conserved se-
quences. There were five conserved types that differed at 4 to
18 amino acid positions. Two additional types (types 6 and 7)
were each found in only one amplicon. The nucleotide se-
quences of individual repeat unit types were very conserved,
with little variation in the third positions of codons. The de-
duced amino acid sequence of E. chaffeensis Wakulla, the only
example of a six-repeat unit VLPT in our series, is shown in
Fig. 3, and the repeat units are numbered to illustrate the five
conserved types. A total of six different repeat profiles (number
and order of repeat unit types) were represented among the
FIG. 1. Nucleotide and deduced amino acid sequences of the E. chaffeensis
Arkansas VLPT. The following features are indicated in boldface type: putative
ribosome-binding site (RBS), translation initiation codon, and termination
codon (asterisk). An aspartic acid codon (GAT) and the sequence 59-GTTTTA
TAT, which are absent from sequences amplified from some strains of E.
chaffeensis, and four individual nucleotide positions where substitutions (A or G)
occur among different strains are also indicated in boldface type. PCR primers
are underlined and labeled, and directions are indicated. The nucleotide se-
quence was numbered by designating the A of the putative translation initiation
codon number 1.
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VLPT sequences amplified from isolates and patient whole
blood (Table 1). Repeat types are listed in the downstream-
to-upstream orientation. Type 1 represents the partial repeat
always found the farthest downstream (Fig. 3). Among the
amplicon sequences containing three or four repeats, the types
and linear order of repeat units were conserved (e.g., 1, 2, 4
and 1, 2, 3, 4). Amplicons containing more than four repeat
units usually contained a duplication of the type 3 unit or the
addition of a type 5 unit. Among the amplicon sequences
containing five repeats, we found three variations in the types
and order of repeat units (Table 1).
In seven of the amplicons (representing one isolate, four
patient blood samples, and two tick pools), three nucleotides
representing an aspartic acid codon were absent. When present,
this aspartic acid residue was the 17th residue from the amino
terminus and immediately preceded the beginning of the first
repeat unit.
A gap consisting of a nine-nucleotide deletion (59-GTTTT
ATAT) occurred in the same position in seven amplicons (rep-
resenting one isolate, four patient samples, and two tick pools).
The G in this sequence is located 45 nucleotides downstream
of the putative stop codon, and the sequence is marked in
boldface type in Fig. 1. A repetitive motif (GTTTT) that may
facilitate recombination was found in this region. The nine-
base gap and the aspartic acid deletions were found more often
in the amplicons with a larger number of repeats, and these
deletions were always associated with each other in amplicons
TABLE 1. Summary of VLPT sequence variation
Sample Geographicorigin
No. of
repeat
units
Repeat
profile
A or G at
position 269
A or G at
position 6
A or G at
position
27
A or G at
position
487
Aspartic
acid
deletion
Presence of
nine-base
gap
No. of repeats
in 120-kDa
antigen genea
Arkansas isolate Arkansas 4 1, 2, 3, 4 A A G G No No 4
91HE17 isolate Arkansas 5 1, 2, 3, 3, 4 A A G G No No 4
Sapulpa isolate Oklahoma 3 1, 2, 4 A A G G No No 3
Jax isolate Florida 4 1, 2, 3, 4 A A G G No No 4
St. Vincent isolate Georgiab 3 1, 2, 4 A A G G No No 3
Osceola isolate Florida 4 1, 2, 3, 4 A A G G No No 3
Wakulla isolate Florida 6 1, 2, 3, 3, 4, 5 G G A A Yes Yes 4
Liberty isolate Florida 4 1, 2, 3, 4 G G G G No No 4
West Paces isolate Tennessee 3 1, 2, 4 A A G G No No 3
Patient 1 blood Arkansas 5 1, 2, 3, 4, 5 G G A A Yes Yes NDc
Patient 2 blood Texas 5 1, 2, 3, 3, 4 A A G G No No ND
Patient 3 blood Florida 5 1, 2, 3, 4, 5 G G A A Yes Yes ND
Patient 4 blood Delaware 5 1, 2, 6, 4, 5 G G A A Yes Yes ND
Patient 5 blood Maryland 4 1, 2, 3, 4 A A G G No No ND
Patient 6 blood Florida 4 1, 2, 3, 4 A A G G No No ND
Patient 7 blood Maryland 5 1, 2, 3, 4, 5 G G A A Yes Yes ND
Tick 97-36 Florida 4 1, 2, 3, 4 ND A G ND No ND ND
Tick pool 9 Missouri 5 1, 2, 3, 4, 5 G G A G Yes No 4
Tick pool 20 North Carolina 4 1, 2, 3, 4 G A G A No No 3
Tick pool 25 Kentucky 5 1, 2, 3, 3, 4 A A G G No No 4
Tick pool 85 North Carolina 4 1, 2, 3, 4 G A G A No Yes 3
Tick pool 95 North Carolina 3 1, 2, 4 A A G A No Yes 3
Tick pool 97 North Carolina 4 1, 2, 3, 4 A A G G No No 3
Tick pool 130 North Carolina 4 1, 2, 3, 7 A G A A Yes No 4
a The 120-kDa antigen gene PCR results for tick pools were taken from Yu et al. (30).
b Florida patient with history of tick exposure in Georgia.
c ND, not done.
FIG. 2. Agarose gel electrophoresis of PCR products amplified from differ-
ent cell culture isolates of E. chaffeensis and control samples with VLPT primers
FB5A and FB3A. Lanes: A, water; B, extraction blank; C, uninfected DH82 cells;
D, St. Vincent; E, Arkansas; F, Jax; G, Osceola; H, 91HE17; I, Wakulla. The
outside lanes contain fX174/HaeIII molecular mass markers.
TABLE 2. Collection information and PCR results for pools of
adult A. americanum ticks
Tick
pool no.
No. of ticks
in pool State of origin
16S rRNA
PCR
resulta
VLPT
PCR
result
120-kDa gene
PCR resultb
9 10 Missouri 1 1 1
20 12 North Carolina 1 1 1
25 2 Kentucky 1 1 1
85 10 North Carolina 1 1 1
95 10 North Carolina 1 1 1
97 10 North Carolina 1 1 1
130 10 North Carolina 1 1 1
13 4 Missouri 2 2 NDc
21 2 Missouri 2 2 ND
219 8 Missouri 2 2 ND
a The 16S rRNA gene PCR results for positive pools were taken from Ander-
son et al. (4).
b The 120-kDa antigen gene PCR results were taken from Yu et al. (30).
c ND, not done.
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derived from the isolates and patient blood samples but not the
tick pools.
Adenosine or guanosine substitutions were found primarily
at four distinct positions (positions 269, 6, 27, and 487) among
the different VLPT amplicons (Table 1). Nucleotide substitu-
tions at positions 27 and 487 resulted in amino acid substitu-
tions from methionine to isoleucine and serine to glycine, re-
spectively. Position 6 corresponds to the second nucleotide
from the 39 end of primer FB5. We are currently evaluating the
use of a primer slightly upstream of FB5, because sequence
variation in the primer site could adversely affect PCR sensi-
tivity.
In summary, among the three-repeat-unit varieties, the
Sapulpa, St. Vincent, and West Paces isolates had identical
sequences, but the sequence of the amplicon from tick pool 95
differed at position 487 and had the 9-base gap. Among the
four-repeat-unit varieties, amplicons from the Arkansas, Jax,
and Osceola isolates, patient 5, patient 6, and tick pool 97 had
identical VLPT sequences, although the Osceola isolate had a
three-repeat-unit version of the 120-kDa antigen gene and the
others had the four-repeat-unit version. The sequences of the
remaining four-repeat-unit versions, those from tick pools 20,
85, and 130 and the Liberty isolate, are different from those
listed above and from each other. Among the five-repeat-unit
varieties, amplicons from the 91HE17 isolate, patient 2, and
tick pool 25 had identical VLPT sequences. Amplicons from
patients 1, 3, and 7 had identical sequences, and the sequences
from patient 4 and tick pool 9 were unique. The Wakulla
isolate contained six repeat units.
Expression of VLPT protein from cloned amplicons. Ampli-
cons from the St. Vincent, Jax, and 91HE17 isolates (repre-
senting the three-, four-, and five-repeat-unit versions, respec-
tively) were cloned into an expression vector, and E. coli lysates
were examined for expression of the VLPT protein. The VLPT
genes of the Arkansas and Jax isolates were equal in size (four
repeat units) and expressed comigrating proteins. The proteins
expressed by the St. Vincent and 91HE17 clones were propor-
tional to the sizes of the ORFs (Fig. 4). Expression of the
VLPT was cytotoxic to E. coli, resulting in colonies approxi-
mately a quarter the size of those produced by the same strain
of E. coli not transformed with a recombinant plasmid con-
taining the VLPT insert.
Amplification of 120-kDa antigen gene. PCR amplification
of the E. chaffeensis 120-kDa antigen gene was performed to
additionally characterize each isolate, because variation among
strains was described previously (30). Two size variants were
found (Table 1), and these corresponded to the three- and
four-repeat-unit versions described previously (6, 30) in the
Sapulpa and Arkansas strains of E. chaffeensis, respectively.
The Osceola, St. Vincent, and West Paces isolates produced
amplicons of the same size as that produced by the Sapulpa
strain, and the Jax, Wakulla, Liberty, and 91HE17 isolates
produced amplicons of the same size as that produced by the
Arkansas strain. These amplicons were partially sequenced
with a single primer to confirm their identities. The corre-
sponding patient blood samples were not tested. DNA samples
from the tick pools were previously tested by PCR with the
120-kDa antigen gene primers (30), and one of the two size
variations (e.g., three or four repeat units) was found in each
pool (Table 1).
DISCUSSION
In this report we present the results of the cloning, se-
quencing, and expression of a previously uncharacterized E.
chaffeensis gene and describe a wide range of sequence varia-
tion among PCR amplicons derived from different isolates,
patient samples, and ticks. The VLPT gene appears to be a
sensitive and specific marker for E. chaffeensis. This gene has
multiple diagnostic applications and represents a potentially
important tool for the study of the molecular epidemiology of
E. chaffeensis. The VLPT gene conveniently differentiates
strains of E. chaffeensis. Some of the established DNA finger-
printing techniques for the detection of genetic diversity
among strains of bacteria, such as arbitrary primed PCR (ran-
domly amplified polymorphic DNA [RAPD] PCR [RAPD-
PCR]), have the advantage of targeting the entire genome and
require little knowledge of the nucleotide sequence (26). How-
ever, RAPD-PCR is difficult to apply to obligate intracellular
bacteria, primarily because of problems associated with con-
tamination of preparations with host-cell DNA. Consequently,
conserved genes or regions of known sequence must be tar-
geted.
Two of the first Ehrlichia genes sequenced, the 16S rRNA
gene (1) and the groESL operon (24), appear to be completely
conserved among several isolates of E. chaffeensis (19). Anal-
ysis of tRNA interrepeat length polymorphisms has been used
FIG. 3. Deduced amino acid sequence of the VLPT gene of E. chaffeensis
Wakulla with the six repeat units aligned and numbered according to sequence
type. Repeat units with conserved sequences were categorized and numbered to
facilitate description of genetic variation. Repeat unit types and the order in
which they occur vary among some strains.
FIG. 4. Western immunoblot reacted with anti-E. chaffeensis HMAF showing
the proteins expressed by three different size variations of the VLPT gene. The
lanes contained lysates from purified E. chaffeensis Arkansas (lane Ec) E. coli
transformed with a VLPT clone selected from the E. chaffeensis Arkansas
genomic library (lane Ac), and E. coli transformed with plasmids containing PCR
amplicons from the following strains: St. Vincent (lane 3R), Jax (lane 4R), and
91HE17 (lane 5R) (R indicates the number of 90-bp repeat units found in the
VLPT gene of each strain).
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to detect and differentiate Ehrlichia species (9), but the utility
of this method for the detection of differences among strains of
the same species has not been determined. Two E. chaffeensis
genes for which isolate-dependent sequence polymorphisms
have been demonstrated are the 120-kDa antigen gene (29)
and the VLPT described in this report. PCR amplification and
nucleotide sequencing of the VLPT repeat region are conve-
nient and more informative than PCR amplification and nu-
cleotide sequencing of the 120-kDa antigen gene because of
the smaller size of the VLPT repeat region and the greater
variability in the number of repeat units. Finer resolution can
be obtained by combining data obtained from assays with these
genes. Interestingly, among the samples for which the number
of repeats have been determined for both genes, there appears
to be some correlation between gene sizes. In our study, the
three-repeat-unit version of the 120-kDa antigen was always
associated with fewer (e.g., three or four) repeat units in the
VLPT. We have not detected any significant sequence homol-
ogy between these two genes. The recently described p28 an-
tigen gene family of E. chaffeensis may also prove to be useful
for the study of strain variation (18), since variation was de-
tected in a related gene family, map-1 of C. ruminantium (21).
On a practical level, VLPT PCR is useful when conducting
experiments involving different strains of E. chaffeensis. We
have found it to be convenient to use DNA extracted from the
Wakulla isolate as a positive PCR control. To date, the six-
repeat version found in the Wakulla isolate appears to be
relatively rare, and its use allows us to discern false-positive
PCR results that might result from contamination of test sam-
ples with amplicons derived from a positive control. This is
particularly important when nested PCR is used. Isolates and
patient samples are easily identified by the VLPT size differ-
ences determined by gel electrophoresis of PCR amplicons.
However, if sequencing is available, other variations at the
nucleotide level may be discerned, allowing even finer separa-
tion. These variations include the presence or absence of the
aspartic acid codon preceding the repeat region, the presence
or absence of a 9-bp gap beyond the coding sequence, and
individual nucleotide substitutions that occur at defined posi-
tions. Isolates, patient blood samples, and tick samples (24
total samples) could be segregated into 12 different groups by
using information derived from individual VLPT sequences.
On an epidemiologic level, it would be interesting to find a
correlation between the geographic origin of samples and vari-
ations in gene sequences. A previous report on the geographic
distribution of variants of the 120-kDa antigen gene failed to
demonstrate convincing geographic clustering of three- and
four-repeat-unit variants among DNA samples from tick pools.
All tick pools showed a single PCR band, suggesting that a
single-repeat variant was present in each pool (30). We were
not able to identify obvious patterns among VLPT sequences
from similar geographic locations, but relatively few samples
have been tested. The ticks included in each individual pool
were collected in the same county, and we were interested to
see whether we would find more than one version of the VLPT
in a single pool. A single tick pool produced two amplicons that
comigrated with the VLPT markers, suggesting the presence of
two versions in the same pool; however, the second (less in-
tense) band could not be recovered in sufficient quantity to
verify its identity by sequencing. We are currently developing
labeled probes for confirmation of amplicon identity by hybrid-
ization methods. Amplicons were separated by gel electro-
phoresis, but different sequence types with the same number of
repeats would not have separated. Although the electrophero-
grams did not reveal ambiguities, sequence data from the tick
pools should probably be interpreted with more caution than
sequence data derived from isolates and patient blood samples.
The VLPT PCR appears to be as sensitive as 16S rDNA PCR
for the detection of E. chaffeensis and produces less back-
ground, particularly with ticks.
Current data do not allow us to determine the frequency
with which VLPT sequences change or whether changes occur
randomly or may be associated with the function of the pro-
tein. The wide geographic distribution of different sequence
types may indicate frequent change. However, in a limited
number of passages, isolate-specific sequence patterns re-
mained stable in cell culture, suggesting that this gene could be
used as a reliable marker to distinguish among isolates of E.
chaffeensis.
The VLPT ORFs of the St. Vincent, Jax, and 91HE17 iso-
lates code for polypeptides of 168, 198, and 228 amino acids,
respectively. The corresponding calculated molecular masses
(without posttranslational modification) are 19, 22, and 25
kDa. The apparent molecular masses of the VLPT proteins
(Fig. 4) derived by electrophoretic mobility were approxi-
mately twice those calculated from the length of the ORF. The
cause of this discrepancy remains to be determined. The E.
chaffeensis 120-kDa antigen also migrates as though it has a
molecular mass much higher than that predicted from the
length of the ORF (29).
In our laboratory, characterization of the VLPT gene was
concurrent with efforts to obtain new isolates of E. chaffeensis.
The latter efforts produced six new isolates, and we naturally
concentrated our efforts on using the VLPT gene as a tool for
the differentiation of these isolates. Fundamental immunologic
investigations on the role of this gene, the cellular location of
the gene product, and its potential use as a diagnostic reagent
remain.
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